Oluseye Ogunmoroti1,2, Olatokunbo Osibogun1,3, Lena Mathews1,2, Olumuyiwa A Esuruoso4, Chiadi E Ndumele1,2, Victor Okunrintemi5, Gregory L Burke6, Roger S Blumenthal1,2, Matthew J Budoff7, Erin D Michos1,2. 1. Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD (O. Ogunmoroti, L.M., C.E.N., R.S.B., E.D.M.). 2. Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (O. Ogunmoroti, L.M., C.E.N., R.S.B., E.D.M.). 3. Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami' FL (O. Osibogun). 4. Division of General Internal Medicine, Meharry Medical College, Nashville, TN (O.A.E.). 5. Division of Cardiovascular Disease, Houston Methodist Hospital, TX (V.O.). 6. Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC (G.L.B.). 7. Department of Medicine, Lundquist Institute at Harbor-UCLA, Torrance, CA (M.J.B.).
Abstract
BACKGROUND: Ideal cardiovascular health (CVH) is associated with a lower incidence of cardiovascular disease. Extracoronary calcification (ECC)-measured at the aortic valve, mitral annulus, ascending thoracic aorta, and descending thoracic aorta-is an indicator of systemic atherosclerosis. This study examined whether favorable CVH was associated with a lower risk of ECC. METHODS: We analyzed data from MESA (Multi-Ethnic Study of Atherosclerosis) participants aged 45 to 84 years without cardiovascular disease at baseline. ECC was measured by noncontrast cardiac computed tomography scan at baseline and after an average of 2.4 years. Prevalent ECC was defined as an Agatston score >0 at the baseline scan. Incident ECC was defined as Agatston score >0 at the follow-up scan among participants with Agatston score of 0 at the baseline scan. Each CVH metric (smoking, physical activity, body mass index, diet, blood pressure, total cholesterol, and blood glucose) was scored 0 to 2 points, with 2 indicating ideal; 1, intermediate; and 0, poor. The aggregated CVH score was 0 to 14 points (0-8, inadequate; 9-10, average; 11-14, optimal). We used Poisson and linear mixed-effects regression models to examine the association between CVH and ECC adjusted for sociodemographic factors. RESULTS: Of 6504 participants, 53% were women with a mean age (SD) of 62 (10) years. Optimal and average CVH scores were associated with lower ECC prevalence, incidence, and extent. For example, optimal CVH scores were associated with 57%, 56%, 70%, and 54% lower risk of incident aortic valve calcification, mitral annulus calcification, ascending thoracic aorta calcification, and descending thoracic aorta calcification, respectively. In addition, optimal and average CVH scores were associated with lower ECC progression at 2 years, although these associations were only significant for mitral annulus calcification and descending thoracic aorta calcification. CONCLUSIONS: In this multiethnic cohort, favorable CVH was associated with a lower risk of extracoronary atherosclerosis. These findings emphasize the importance of primordial prevention as an intervention to reduce the burden of cardiovascular disease.
BACKGROUND: Ideal cardiovascular health (CVH) is associated with a lower incidence of cardiovascular disease. Extracoronary calcification (ECC)-measured at the aortic valve, mitral annulus, ascending thoracic aorta, and descending thoracic aorta-is an indicator of systemic atherosclerosis. This study examined whether favorable CVH was associated with a lower risk of ECC. METHODS: We analyzed data from MESA (Multi-Ethnic Study of Atherosclerosis) participants aged 45 to 84 years without cardiovascular disease at baseline. ECC was measured by noncontrast cardiac computed tomography scan at baseline and after an average of 2.4 years. Prevalent ECC was defined as an Agatston score >0 at the baseline scan. Incident ECC was defined as Agatston score >0 at the follow-up scan among participants with Agatston score of 0 at the baseline scan. Each CVH metric (smoking, physical activity, body mass index, diet, blood pressure, total cholesterol, and blood glucose) was scored 0 to 2 points, with 2 indicating ideal; 1, intermediate; and 0, poor. The aggregated CVH score was 0 to 14 points (0-8, inadequate; 9-10, average; 11-14, optimal). We used Poisson and linear mixed-effects regression models to examine the association between CVH and ECC adjusted for sociodemographic factors. RESULTS: Of 6504 participants, 53% were women with a mean age (SD) of 62 (10) years. Optimal and average CVH scores were associated with lower ECC prevalence, incidence, and extent. For example, optimal CVH scores were associated with 57%, 56%, 70%, and 54% lower risk of incident aortic valve calcification, mitral annulus calcification, ascending thoracic aorta calcification, and descending thoracic aorta calcification, respectively. In addition, optimal and average CVH scores were associated with lower ECC progression at 2 years, although these associations were only significant for mitral annulus calcification and descending thoracic aorta calcification. CONCLUSIONS: In this multiethnic cohort, favorable CVH was associated with a lower risk of extracoronary atherosclerosis. These findings emphasize the importance of primordial prevention as an intervention to reduce the burden of cardiovascular disease.
Authors: Oluseye Ogunmoroti; Erin D Michos; Konstantinos N Aronis; Joseph A Salami; Ron Blankstein; Salim S Virani; Erica S Spatz; Norrina B Allen; Jamal S Rana; Roger S Blumenthal; Emir Veledar; Moyses Szklo; Michael J Blaha; Khurram Nasir Journal: Atherosclerosis Date: 2018-06-02 Impact factor: 5.162
Authors: Khurram Nasir; Ronit Katz; Junichiro Takasu; David M Shavelle; Robert Detrano; Joao A Lima; Roger S Blumenthal; Kevin O'Brien; Matthew J Budoff Journal: Atherosclerosis Date: 2007-10-24 Impact factor: 5.162
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Salim S Virani; Alvaro Alonso; Hugo J Aparicio; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Susan Cheng; Francesca N Delling; Mitchell S V Elkind; Kelly R Evenson; Jane F Ferguson; Deepak K Gupta; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Chong D Lee; Tené T Lewis; Junxiu Liu; Matthew Shane Loop; Pamela L Lutsey; Jun Ma; Jason Mackey; Seth S Martin; David B Matchar; Michael E Mussolino; Sankar D Navaneethan; Amanda Marma Perak; Gregory A Roth; Zainab Samad; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Andrew Stokes; Lisa B VanWagner; Nae-Yuh Wang; Connie W Tsao Journal: Circulation Date: 2021-01-27 Impact factor: 29.690
Authors: Oluseye Ogunmoroti; Norrina B Allen; Mary Cushman; Erin D Michos; Tatjana Rundek; Jamal S Rana; Ron Blankstein; Roger S Blumenthal; Michael J Blaha; Emir Veledar; Khurram Nasir Journal: J Am Heart Assoc Date: 2016-10-20 Impact factor: 5.501
Authors: Tamar S Polonsky; Hongyan Ning; Martha L Daviglus; Kiang Liu; Gregory L Burke; Mary Cushman; John Eng; Aaron R Folsom; Pamela L Lutsey; Jennifer A Nettleton; Wendy S Post; Ralph L Sacco; Moyses Szklo; Donald M Lloyd-Jones Journal: J Am Heart Assoc Date: 2017-03-20 Impact factor: 5.501
Authors: Morten Sengeløv; Susan Cheng; Tor Biering-Sørensen; Kunihiro Matsushita; Suma Konety; Scott D Solomon; Aaron R Folsom; Amil M Shah Journal: J Am Heart Assoc Date: 2018-02-03 Impact factor: 5.501